N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine

Star0

DB07382ExperimentalSmall molecule

N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine: Overview.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase/endoribonuclease IRE1
Curator reviewed
Formula / weight: C₁₇H₁₆N₈ · 332.3625 g/mol (avg)

Resolves to

Compound

PubChem42627755

Structure

InChIKeyWJNBSTLIALIIEW-UHFFFAOYSA-NSMILESC1CC1C1=NNC(NC2=CC=NC(NC3=CC4=C(NC=N4)C=C3)=N2)=C1

Targets

O75460ERN1

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account